Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 61, Issue 1 , Pages 4-17 , January 2008

Levels of evidence for the treatment of keloid disease

  • P. Durani

      Affiliations

    • Renovo, Manchester Incubator Building, 48 Grafton Street, Manchester M13 9XX, UK
  • ,
  • A. Bayat

      Affiliations

    • Plastic & Reconstructive Surgery Research, Manchester Interdisciplinary Biocentre, University of Manchester, Manchester, UK
    • Corresponding Author InformationCorresponding author. Address: Plastic & Reconstructive Surgery Research, Manchester Interdisciplinary Biocentre, University of Manchester, 131 Princess Street, Manchester M1 7ND, UK. Tel.: +44 0161 306 5177.

Received 23 June 2006 ,Accepted 15 May 2007.

References 

  1. A first class service: quality in the new NHS. London: Department of Health; 1998;(Health Service Circular: HSC(98) 113)
  2. Bayat A, McGrouther DA, Ferguson MW. Skin scarring. BMJ. 2003;326:88–92
  3. Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol. 1994;145:105–113
  4. Bayat A, McGrouther DA. Clinical management of skin scarring. Skinmed. 2005;4:165–173
  5. Murray JC. Keloids and hypertrophic scars. Clin Dermatol. 1994;12:27–37
  6. Mustoe TA, Cooter RD, Gold MH, et al. International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–571
  7. Kiil J. Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg. 1977;11:169–172
  8. Griffith BH, Monroe CW, McKinney P. A follow-up study on the treatment of keloids with triamicinolone acetonide. Plast Reconstr Surg. 1970;46:145–150
  9. Niessen FB, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104:1435–1458
  10. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46(Suppl. Understanding):S63–S97
  11. Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther. 2004;17:212–218
  12. Al-Attar A, Mess S, Thomassen JM, et al. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117:286–300
  13. Ball C, Sackett D, Phillips B, et al. Levels of Evidence and Grades of Recommendation. Oxford: Centre for Evidence-Based Medicine; 2001;http://www.cebm.net/levels_of_evidence.asp
  14. Sawada Y, Sone K. Treatment of scars and keloids with a cream containing silicone oil. Br J Plast Surg. 1990;43:683–688
  15. Palmieri B, Gozzi G, Palmieri G. Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids. Int J Derm. 1995;34:506–509
  16. Sawada Y, Sone K. Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg. 1992;45:599–603
  17. Chang CC, Kuo YF, Chiu HC, et al. Hydration, not silicone, modulates the effects of keratinocytes on fibroblasts. J Surg Res. 1995;59:705–711
  18. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol. 1994;30:506–507
  19. de Oliveira GV, Nunes TA, Magna LA, et al. Silicone versus nonsilicone gel dressings: a controlled trial. Dermatol Surg. 2001;27:721–726
  20. Berman B, Flores F. Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic or keloid scars. Dermatol Surg. 1999;25:484–486
  21. Fulton JE. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg. 1995;21:947–951
  22. Gold MH. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. A dermatologic experience. J Dermatol Surg Oncol. 1993;19:912–916
  23. Dockery GL, Nilson RZ. Treatment of hypertrophic and keloid scars with silastic gel sheeting. J Foot Ankle Surg. 1994;33:110–119
  24. Mercer NS. Silicone gel in the treatment of keloid scars. Br J Plast Surg. 1989;42:83–87
  25. Quinn KJ. Silicone gel in scar treatment. Burns Incl Therm Inj. 1987;13(Suppl.):S33–S40
  26. Ohmori S. Effectiveness of silastic sheet coverage in the treatment of scar keloid (hypertrophic scar). Aesthetic Plast Surg. 1988;12:95–99
  27. Chuangsuwanich A, Osathalert V, Muangsombut S. Self-adhesive silicone gel sheet: a treatment for hypertrophic scars and keloids. J Med Assoc Thai. 2000;83:439–444
  28. Hirshowitz B, Lindenbaum E, Har-Shai Y, et al. Static-electric field induction by a silicone cushion for the treatment of hypertrophic and keloid scars. Plast Reconstr Surg. 1998;101:1173–1183
  29. Wong TW, Chiu HC, Chang CH, et al. Silicone cream occlusive dressing – a novel noninvasive regimen in the treatment of keloid. Dermatology. 1996;192:329–333
  30. Katz BE. Silicone gel sheeting in scar therapy. Cutis. 1995;56:65–67
  31. O'Brien L, Pandit A. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev. 2006;CD003826
  32. McCoy BJ, Diegelmann RF, Cohen IK. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med. 1980;163:216–222
  33. Cruz NI, Korchin L. Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg. 1994;33:401–405
  34. Boyadjiev C, Popchristova E, Mazgalova J. Histomorphologic changes in keloids treated with Kenacort. J Trauma. 1995;38:299–302
  35. Kauh YC, Rouda S, Mondragon G, et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586–589
  36. Darzi MA, Chowdri NA, Kaul SK, et al. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg. 1992;45:374–379
  37. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol. 1994;130:498–501
  38. Yosipovitch G, Widijanti Sugeng M, Goon A, et al. A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: a controlled study. J Dermatolog Treat. 2001;12:87–90
  39. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138:1149–1155
  40. Boutli-Kasapidou F, Tsakiri A, Anagnostou E, et al. Hypertrophic and keloidal scars: an approach to polytherapy. Int J Dermatol. 2005;44:324–327
  41. Muneuchi G, Suzuki S, Onodera M, et al. Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg. 2006;40:111–116
  42. Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg. 2001;54:633–635
  43. Hirshowitz B, Lerner D, Moscona AR. Treatment of keloid scars by combined cryosurgery and intralesional corticosteroids. Aesthetic Plast Surg. 1982;6:153–158
  44. Russell R, Horlock N, Gault D. Zimmer splintage: a simple effective treatment for keloids following ear-piercing. Br J Plast Surg. 2001;54:509–510
  45. Connell PG, Harland CC. Treatment of keloid scars with pulsed dye laser and intralesional steroid. J Cutan Laser Ther. 2000;2:147–150
  46. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 1999;25:224–232
  47. Yencha MW, Oberman JP. Combined therapy in the treatment of auricular keloids. Ear Nose Throat J. 2006;85:93–94[96–7]
  48. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003;111:1841–1852
  49. Shepherd JP, Dawber RP. The response of keloid scars to cryosurgery. Plast Reconstr Surg. 1982;70:677–682
  50. Muti E, Ponzio E. Cryotherapy in the treatment of keloids. Ann Plast Surg. 1983;11:227–232
  51. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19:529–534
  52. Zouboulis CC, Blume U, Buttner P, et al. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol. 1993;129:1146–1151
  53. Gupta S, Kumar B. Intralesional cryosurgery using lumbar puncture and/or hypodermic needles for large, bulky, recalcitrant keloids. Int J Derm. 2001;40:349–353
  54. Fikrle T, Pizinger K. Cryosurgery in the treatment of earlobe keloids: report of seven cases. Dermatol Surg. 2005;31:1728–1731
  55. de Waard JW, de Man BM, Wobbes T, et al. Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil. Eur J Cancer. 1998;34:162–167
  56. Blumenkranz M, Hernandez E, Ophir A, et al. 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology. 1984;91:122–130
  57. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 2002;204:130–132
  58. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg. 2004;30:54–56
  59. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol. 2004;45:140–143
  60. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52:474–479
  61. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest. 1984;74:1112–1116
  62. Berman B, Duncan MR. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol. 1989;21:694–702
  63. Granstein RD, Rook A, Flotte TJ, et al. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Cinical and histologic findings. Arch Dermatol. 1990;126:1295–1302
  64. al-Khawajah MM. Failure of interferon-alpha 2b in the treatment of mature keloids. Int J Dermatol. 1996;35:515–517
  65. Larrabee WF, East CA, Jaffe HS, et al. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg. 1990;116:1159–1162
  66. Conejo-Mir JS, Corbi R, Linares M. Carbon dioxide laser ablation associated with interferon alfa-2b injections reduces the recurrence of keloids. J Am Acad Dermatol. 1998;39:1039–1040
  67. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet. 1995;345:1198–1200
  68. Paquet P, Hermanns JF, Pierard GE. Effect of the 585 nm flashlamp-pumped pulsed dye laser for the treatment of keloids. Dermatol Surg. 2001;27:171–174
  69. Dierickx C, Goldman MP, Fitzpatrick RE. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plast Reconstr Surg. 1995;95:84–90
  70. Abergel RP, Dwyer RM, Meeker CA, et al. Laser treatment of keloids: a clinical trial and an in vitro study with Nd:YAG laser. Lasers Surg Med. 1984;4:291–295
  71. Sherman R, Rosenfeld H. Experience with the Nd:YAG laser in the treatment of keloid scars. Ann Plast Surg. 1988;21:231–235
  72. Kumar K, Kapoor BS, Rai P, et al. In-situ irradiation of keloid scars with Nd:YAG laser. J Wound Care. 2000;9:213–215
  73. Henderson DL, Cromwell TA, Mes LG. Argon and carbon dioxide laser treatment of hypertrophic and keloid scars. Lasers Surg Med. 1984;3:271–277
  74. Kantor GR, Wheeland RG, Bailin PL, et al. Treatment of earlobe keloids with carbon dioxide laser excision: a report of 16 cases. J Dermatol Surg Oncol. 1985;11:1063–1067
  75. Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg. 1992;118:63–67
  76. Apfelberg DB, Maser MR, White DN, et al. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med. 1989;9:382–388
  77. Stern JC, Lucente FE. Carbon dioxide laser excision of earlobe keloids. A prospective study and critical analysis of existing data. Arch Otolaryngol Head Neck Surg. 1989;115:1107–1111
  78. Norris JE. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg. 1991;87:44–49
  79. Hulsbergen Henning JP, Roskam Y, van Gemert MJ. Treatment of keloids and hypertrophic scars with an argon laser. Lasers Surg Med. 1986;6:72–75
  80. Apfelberg DB, Maser MR, Lash H, et al. Preliminary results of argon and carbon dioxide laser treatment of keloid scars. Lasers Surg Med. 1984;4:283–290
  81. Lee Y, Minn KW, Baek RM, et al. A new surgical treatment of keloid: keloid core excision. Ann Plast Surg. 2001;46:135–140
  82. Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg. 1991;27:164–178
  83. Shons AR, Press BH. The treatment of earlobe keloids by surgical excision and postoperative triamcinolone injection. Ann Plast Surg. 1983;10:480–482
  84. Golladay ES. Treatment of keloids by single intraoperative perilesional injection of repository steroid. South Med J. 1988;81:736–738
  85. Tang YW. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg. 1992;45:371–373
  86. Chowdri NA, Masarat M, Mattoo A, et al. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg. 1999;69:655–659
  87. Talmi YP, Orenstein A, Wolf M, et al. Use of mitomycin C for treatment of keloid: a preliminary report. Otolaryngol Head Neck Surg. 2005;132:598–601
  88. Sanders KW, Gage-White L, Stucker FJ. Topical mitomycin C in the prevention of keloid scar recurrence. Arch Facial Plast Surg. 2005;7:172–175
  89. Copcu E, Sivrioglu N, Oztan Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J Burn Care Rehabil. 2004;25:1–7
  90. Rehman J, Benet A, Melman A. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology. 1998;51:620–626
  91. Lawrence WT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg. 1996;37:167–169
  92. D'Andrea F, Brongo S, Ferraro G, et al. Prevention and treatment of keloids with intralesional verapamil. Dermatology. 2002;204:60–62
  93. Broker BJ, Rosen D, Amsberry J, et al. Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: a pilot study. Laryngoscope. 1996;106:1497–1501
  94. Davison SP, Mess S, Kauffman LC, et al. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg. 2006;117:247–252
  95. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol. 1997;37:755–757
  96. Uppal RS, Khan U, Kakar S, et al. The effects of a single dose of 5-fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg. 2001;108:1218–1224
  97. Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids. J Am Acad Dermatol. 2002;47(Suppl. 4):S209–S211
  98. Martin-Garcia RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg. 2005;31:1394–1398
  99. Brent B. The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Surg. 1978;1:579–581
  100. Rauscher GE, Kolmer WL. Treatment of recurrent earlobe keloids. Cutis. 1986;37:67–68
  101. Sclafani AP, Gordon L, Chadha M, et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg. 1996;22:569–574
  102. Ollstein RN, Siegel HW, Gillooley JF, et al. Treatment of keloids by combined surgical excision and immediate postoperative X-ray therapy. Ann Plast Surg. 1981;7:281–285
  103. Enhamre A, Hammar H. Treatment of keloids with excision and postoperative X-ray irradiation. Dermatologica. 1983;167:90–93
  104. Borok TL, Bray M, Sinclair I, et al. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys. 1988;15:865–870
  105. Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: a 20-year experience. Int J Radiat Oncol Biol Phys. 1989;17:77–80
  106. Sallstrom KO, Larson O, Heden P, et al. Treatment of keloids with surgical excision and postoperative X-ray radiation. Scand J Plast Reconstr Surg Hand Surg. 1989;23:211–215
  107. Doornbos JF, Stoffel TJ, Hass AC, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys. 1990;18:833–839
  108. Chen HC, Ou SY, Lai YL. Combined surgery and irradiation for treatment of hypertrophic scars and keloids. Chin Med J. 1991;47:249–254
  109. Supe SS, Supe SJ, Rao SM, et al. Treatment of keloids by 90Sr-–90Y beta-rays. Strahlenther Onkol. 1991;167:397–402
  110. Ship AG, Weiss PR, Mincer FR, et al. Sternal keloids: successful treatment employing surgery and adjunctive radiation. Ann Plast Surg. 1993;31:481–487
  111. Escarmant P, Zimmermann S, Amar A, et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys. 1993;26:245–251
  112. Klumpar DI, Murray JC, Anscher M. Keloids treated with excision followed by radiation therapy. J Am Acad Dermatol. 1994;31:225–231
  113. Chaudhry MR, Akhtar S, Duvalsaint F, et al. Ear lobe keloids, surgical excision followed by radiation therapy: a 10-year experience. Ear Nose Throat J. 1994;73:779–781
  114. Durosinmi-Etti FA, Olasinde TA, Solarin EO. A short course postoperative radiotherapy regime for keloid scars in Nigeria. West Afr J Med. 1994;13:17–19
  115. Norris JE. Superficial X-ray therapy in keloid management: a retrospective study of 24 cases and literature review. Plast Reconstr Surg. 1995;95:1051–1055
  116. Clavere P, Bedane C, Bonnetblanc JM, et al. Postoperative interstitial radiotherapy of keloids by iridium 192: a retrospective study of 46 treated scars. Dermatology. 1997;195:349–352
  117. Wagner W, Alfrink M, Micke O, et al. Results of prophylactic irradiation in patients with resected keloids – a retrospective analysis. Acta Oncol. 2000;39:217–220
  118. Guix B, Henriquez I, Andres A, et al. Treatment of keloids by high-dose-rate brachytherapy: a seven-year study. Int J Radiat Oncol Biol Phys. 2001;50:167–172
  119. Ragoowansi R, Cornes PG, Glees JP, et al. Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg. 2001;54:504–508
  120. Caccialanza M, Piccinno R, Schiera A. Postoperative radiotherapy of keloids: a twenty-year experience. Eur J Dermatol. 2002;12:58–62
  121. Maarouf M, Schleicher U, Schmachtenberg A, et al. Radiotherapy in the management of keloids. Clinical experience with electron beam irradiation and comparison with X-ray therapy. Strahlenther Onkol. 2002;178:330–335
  122. Ragoowansi R, Cornes PG, Moss AL, et al. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg. 2003;111:1853–1859
  123. Ogawa R, Mitsuhashi K, Hyakusoku H, et al. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111:547–553
  124. Garg MK, Weiss P, Sharma AK, et al. Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation. Radiother Oncol. 2004;73:233–236
  125. Malaker K, Zaidi M, Franka MR. Treatment of earlobe keloids using the cobalt 60 teletherapy unit. Ann Plast Surg. 2004;52:602–604
  126. Fraunholz IB, Gerstenhauer A, Bottcher HD. Results of postoperative (90)Sr radiotherapy of keloids in view of patients' subjective assessment. Strahlenther Onkol. 2005;181:724–729
  127. Lindsey WH, Davis PT. Facial keloids. A 15-year experience. Arch Otolaryngol Head Neck Surg. 1997;123:397–400
  128. Agrawal K, Panda KN, Arumugam A. An inexpensive self fabricated pressure clip for the ear lobe. Br J Plast Surg. 1998;51:122–123
  129. Akoz T, Gideroglu K, Akan M. Combination of different techniques for the treatment of earlobe keloids. Aesthetic Plast Surg. 2002;26:184–188
  130. Malaker K, Vijayraghavan K, Hodson I, et al. Retrospective analysis of treatment of unresectable keloids with primary radiation over 25 years. Clin Oncol (R Coll Radiol). 2004;16:290–298
  131. Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27:23–27
  132. Saray Y, Gulec AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Derm. 2005;44:777–784
  133. Janssen de Limpens AM. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol. 1980;103:319–323
  134. Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol. 1988;14:1275–1276
  135. Soderberg T, Hallmans G, Bartholdson L. Treatment of keloids and hypertrophic scars with adhesive zinc tape. Scand J Plast Reconstr Surg. 1982;16:261–266
  136. Phillips TJ, Gerstein AD, Lordan V. A randomized controlled trial of hydrocolloid dressing in the treatment of hypertrophic scars and keloids. Dermatol Surg. 1996;22:775–778
  137. Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ. 1998;317:1185–1190
  138. Offer GJ, Perks AG. In search of evidence-based plastic surgery: the problems faced by the specialty. Br J Plast Surg. 2000;53:427–433
  139. Bayat A, Arscott G, Ollier WE, et al. Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population. Br J Plast Surg. 2004;57:122–133
  140. Bayat A, Arscott G, Ollier WE, et al. Keloid disease: clinical relevance of single versus multiple site scars. Br J Plast Surg. 2005;58:28–37
  141. Bayat A, Arscott G, Ollier WE, et al. “Aggressive keloid”: a severe variant of familial keloid scarring. J R Soc Med. 2003;96:554–555
  142. Burd A, Huang L. Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg. 2005;116:150e–157e
  143. Beausang E, Floyd H, Dunn KW, et al. A new quantitative scale for clinical scar assessment. Plast Reconstr Surg. 1998;102:1954–1961
  144. van de Kar AL, Corion LU, Smeulders MJ, et al. Reliable and feasible evaluation of linear scars by the patient and observer scar assessment scale. Plast Reconstr Surg. 2005;116:514–522
  145. Draaijers LJ, Tempelman FR, Botman YA, et al. Colour evaluation in scars: tristimulus colorimeter, narrow-band simple reflectance meter or subjective evaluation?. Burns. 2004;30:103–107
  146. Taylor B, McGrouther DA, Bayat A. Use of a non-contact 3D digitiser to measure the volume of keloid scars: a useful tool for scar assessment. J Plast Reconstr Aesthet Surg. 2007;60:87–94
  147. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191–1194
  148. Gerritsen AA, de Vet HC, Scholten RJ, et al. Enabling meta-analysis in systematic reviews on carpal tunnel syndrome. J Hand Surg [Am]. 2002;27:828–832

 Statement of Possible Competing Interests:PD is employed by Renovo plc, a biotechnology company developing anti-scarring pharmaceuticals. He is developing a patient reported outcomes measure of scarring and this work is being funded by Renovo.

☆☆ This work was accepted for presentation at IPRAS 2007 in Berlin, Germany.

PII: S1748-6815(07)00286-0

doi: 10.1016/j.bjps.2007.05.007

Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 61, Issue 1 , Pages 4-17 , January 2008